ArticleCancer communications (London, England)2025

Reflections and insights into the evolution of restrictive eligibility criteria for cancer clinical trials in China and beyond.

Huiyao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.